Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC vs FFP in Reducing Perioperative Blood Loss in Cardiac Surgery
NCT04244981Phase 4Terminated
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Oct 2023
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prothrombin complex concentrate, human in coagulopathy (2 arms), sponsored by CSPC Pharmaceutical Group. Primary endpoint: Cumulative Chest Tube Drainage at 24 hours. Started Oct 2023; status: terminated.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT04244981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04244981.